Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Adverse Cardiac Events in Breast Cancer Therapy (PACE in Breast Cancer)

NCT00875238 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00875238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00875238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Adverse Cardiac Events in Breast Cancer Therapy (PACE in Breast Cancer)
Lead sponsor
Vanderbilt University
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
March 31, 2015
Enrollment
133 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiac toxicity, cardiovascular complications